NRx Pharmaceuticals, Inc. Stock News

RADNOR, Pa., Aug. 23, 2021 /PRNewswire/ -- NRx Pharmaceuticals (NRx) (Nasdaq: NRXP), a clinical stage, biopharmaceutical company noted today reports1 in the Israeli media that participants in the Br

NRx Pharmaceuticals Inc (NASDAQ: NRXP) stock shed yesterday's gains after announcing a private placement of 2.72 million shares. The purchase price for one share of common stock and one investment o

The company announced a price placement for more than 2.7 million new shares and stock options.

RADNOR, Pa., Aug. 19, 2021 /PRNewswire/ -- NRx Pharmaceuticals (NRx) (Nasdaq: NRXP) (or the "Company"), a Delaware corporation, today announced that it has entered into definitive agreements with in

The company provided a positive update from a clinical study evaluating its COVID-19 therapy Zyesami.

Rx Pharmaceuticals Inc (NASDAQ: NRXP) shares are up around 25% during mid-day session on mild volume, in reaction to safety update on Zyesami (aviptadil) ACTIV-3 Critical Care Phase 3 study in COVI

RADNOR, Pa., Aug. 18, 2021 /PRNewswire/ -- NRx Pharmaceuticals (NRx) (NASDAQ: NRXP), a clinical stage, biopharmaceutical company today provided a safety update on ZYESAMI™ (aviptadil) which is being

NRx Pharmaceuticals, Inc. (NRXP) CEO Jonathan Javitt on Q2 2021 Results - Earnings Call Transcript

--Company to Host Conference Call August 17, 2021 at 8:30AM ET-- RADNOR, Pa., Aug. 11, 2021 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals (NRx) (Nasdaq: NRXP), a clinical stage, global biopharmaceutical com

NRx Pharmaceuticals Inc (NASDAQ: NRXP) has initiated a phase 2b dose-confirmatory trial of the BriLife vaccine against COVID-19 in the Nation of Georgia.  The vaccine is developed by the Israel In

RADNOR, Pa., Aug. 9, 2021 /PRNewswire/ -- NRx Pharmaceuticals (NRx) (Nasdaq: NRXP), a clinical stage, global biopharmaceutical company today announced it is initiating a phase 2b dose-confirmatory t

The Nation of Georgia's Prime Minister and Minister of Health have issued an Emergency Use Authorization for NRx Pharmaceuticals Inc's (NASDAQ: NRXP) intravenous Zyesami (aviptadil) to treat criti

RADNOR, Pa., July 27, 2021 /PRNewswire/ -- NRx Pharmaceuticals (Nasdaq: NRXP) (NRx), a clinical stage, global biopharmaceutical company, today announced that the Nation of Georgia's Prime Minister and

NRX Pharmaceuticals Inc. (NASDAQ: NRXP) shares rallied higher Friday on continued momentum after the company announced the first successful commercial formulation for Zyesami. The stock was trending o

The stock price of NRX Pharmaceuticals Inc (NASDAQ: NRXP) increased by over 25% pre-market. This is why it happened.